More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

Semaglutide key ingredients in popular weight loss drugs Ozempic and Wegovy can curb alcohol cravings as per a new study Read ...

Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the ...

The intricate landscape of medical research continues to unveil groundbreaking approaches to managing chronic joint health ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Did you know over eight million Nigerians are living with diabetes? Click and discover Inside Nigeria’s diabetes crisis: Lifestyle and more ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.